Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients
ABO incompatibility has long been considered an absolute contraindication for kidney transplantation. However, with the increasing number of patients with ESRD in recent years, ABO-incompatible kidney transplantation (ABOi-KT) has expanded the types of donors by crossing the blood group barrier thro...
Saved in:
| Published in | Transplant immunology Vol. 80; p. 101899 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.10.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | ABO incompatibility has long been considered an absolute contraindication for kidney transplantation. However, with the increasing number of patients with ESRD in recent years, ABO-incompatible kidney transplantation (ABOi-KT) has expanded the types of donors by crossing the blood group barrier through preoperative desensitization therapy. At present, the desensitization protocols consist of removal of preexisting ABO blood group antibody titers and prevention of ABO blood group antibody return. Studies have suggested similar patient and graft survival among ABOi-KT and ABOc-KT recipients. In this review, we will summarize the effective desensitization regimens of ABOi-KT, aiming to explore effective ways to improve the success rate and the long-term survival rate of ABOi-KT recipients.
•ABOi-KT has expanded the types of donors by crossing the blood group barrier through preoperative desensitization therapy.•High antibody titers can lead to antibody-mediated rejection (AMR) and prevent renal transplantation across ABO barriers.•The desensitization protocols consist of removal of preexisting ABO blood group antibody titers and prevention of return.•Accommodation, a condition that no rejection occurs even in the presence of an antibody against donor organs. |
|---|---|
| AbstractList | ABO incompatibility has long been considered an absolute contraindication for kidney transplantation. However, with the increasing number of patients with ESRD in recent years, ABO-incompatible kidney transplantation (ABOi-KT) has expanded the types of donors by crossing the blood group barrier through preoperative desensitization therapy. At present, the desensitization protocols consist of removal of preexisting ABO blood group antibody titers and prevention of ABO blood group antibody return. Studies have suggested similar patient and graft survival among ABOi-KT and ABOc-KT recipients. In this review, we will summarize the effective desensitization regimens of ABOi-KT, aiming to explore effective ways to improve the success rate and the long-term survival rate of ABOi-KT recipients. ABO incompatibility has long been considered an absolute contraindication for kidney transplantation. However, with the increasing number of patients with ESRD in recent years, ABO-incompatible kidney transplantation (ABOi-KT) has expanded the types of donors by crossing the blood group barrier through preoperative desensitization therapy. At present, the desensitization protocols consist of removal of preexisting ABO blood group antibody titers and prevention of ABO blood group antibody return. Studies have suggested similar patient and graft survival among ABOi-KT and ABOc-KT recipients. In this review, we will summarize the effective desensitization regimens of ABOi-KT, aiming to explore effective ways to improve the success rate and the long-term survival rate of ABOi-KT recipients. •ABOi-KT has expanded the types of donors by crossing the blood group barrier through preoperative desensitization therapy.•High antibody titers can lead to antibody-mediated rejection (AMR) and prevent renal transplantation across ABO barriers.•The desensitization protocols consist of removal of preexisting ABO blood group antibody titers and prevention of return.•Accommodation, a condition that no rejection occurs even in the presence of an antibody against donor organs. |
| ArticleNumber | 101899 |
| Author | Yang, Li Ma, Yuhua Man, Jiangwei Niu, Jiping Gui, Huiming |
| Author_xml | – sequence: 1 givenname: Yuhua surname: Ma fullname: Ma, Yuhua organization: Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China – sequence: 2 givenname: Jiangwei surname: Man fullname: Man, Jiangwei organization: Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China – sequence: 3 givenname: Huiming surname: Gui fullname: Gui, Huiming organization: Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China – sequence: 4 givenname: Jiping surname: Niu fullname: Niu, Jiping organization: Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China – sequence: 5 givenname: Li surname: Yang fullname: Yang, Li email: ery_yangli@lzu.edu.cn organization: Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37433394$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kM1qGzEUhUVwiZ20L5BFmGU34-rP0gi6cU3bBAzetGuh0dwhcjzSVJINztNHZtwuu7qce885SN8dmvngAaEHgpcEE_Flv8zRDUuKKbssGqVu0II0sqlXXNEZWmAlRM2o5HN0l9IeY0xXSt6iOZOcMab4Au3X3cl4CwP4XDlfjRHCCNFkd4KqgwQ-uezeig6-yi_lMp6rPsRq_W1X_DYMY7m1B6heXefhXOVofBoPxucpE8G60ZX29BF96M0hwafrvEe_f3z_tXmqt7ufz5v1trYMy1xT2oIhXBJLmgZbwVu-ElhaQYuy3AjCWQugZKM45azpVkVbLnrT29ZSye7R56l3jOHPEVLWg0sWDuVNEI5J04YJqhiltFjpZLUxpBSh12MhauJZE6wvjPVeXxjrC2M9MS6hx2v_sR2g-xf5C7UYvk4GKL88OYg62ULAQucKjay74P7X_w4W2JFa |
| Cites_doi | 10.1097/TP.0000000000002594 10.1111/trf.15672 10.1097/TP.0000000000003496 10.1016/j.transproceed.2015.05.026 10.1097/TP.0b013e31819f2024 10.1016/j.intimp.2006.07.018 10.1016/j.transproceed.2021.07.059 10.1111/petr.12227 10.1111/tri.12979 10.1016/j.immuni.2021.03.013 10.4103/ajts.AJTS_82_19 10.1111/vox.13160 10.1159/000355855 10.1053/j.ajkd.2020.03.029 10.1093/ndt/gfv388 10.1016/S0140-6736(14)61601-9 10.1111/ajt.12920 10.1097/01.tp.0000184622.69708.c1 10.1111/tan.14879 10.1111/ctr.12281 10.1093/ndt/gfw017 10.1111/1744-9987.12745 10.1016/j.transproceed.2013.09.036 10.5500/wjt.v4.i1.18 10.1053/j.ajkd.2019.01.031 10.1111/1744-9987.13548 10.1111/iju.14944 10.1016/S0140-6736(16)32187-0 10.1111/tri.14145 10.1159/000510747 10.1159/000512713 10.1016/j.kint.2016.10.040 10.1073/pnas.1901841116 10.1097/01.tp.0000296103.34735.b8 10.1097/01.TP.0000078622.43689.D4 10.1016/j.trre.2020.100563 10.1111/ajt.14702 10.1097/TP.0b013e31823360cf 10.1016/j.transci.2017.08.009 10.1016/S0140-6736(18)32091-9 10.1111/ajt.12982 10.1016/j.transproceed.2019.01.127 10.1111/ctr.13071 10.1097/TP.0000000000004109 10.1590/1806-9282.66.9.1229 10.1016/j.transproceed.2019.01.002 10.1097/TP.0000000000001002 10.1053/j.ajkd.2019.04.025 10.1002/jca.21857 10.3389/fimmu.2022.932242 10.1111/ajt.13760 10.1111/ctr.13512 10.1111/1744-9987.13495 10.1053/j.ajkd.2016.08.024 10.12659/AJCR.905633 10.1111/trf.13427 10.1016/j.kint.2016.06.009 10.1016/j.amjmed.2012.01.023 10.1097/TP.0000000000000753 10.1007/s40265-018-0943-1 10.1111/imr.12150 10.1016/j.idc.2013.02.005 10.1097/00007890-199801270-00014 10.1007/s00467-022-05583-5 10.1016/j.transproceed.2018.01.028 10.1016/S0140-6736(16)32064-5 10.2215/CJN.00540118 10.1097/CM9.0000000000002138 10.1097/MD.0000000000024853 10.1016/j.transproceed.2021.08.062 10.1038/s41598-020-58436-2 10.1371/journal.pone.0131465 10.1097/TP.0000000000000933 10.1111/iju.14108 10.1111/tri.12616 10.1016/j.transproceed.2020.09.001 10.1111/tri.12412 10.1111/ctr.12624 10.3389/fimmu.2017.00234 10.1038/ki.2011.497 10.1016/j.jfma.2012.12.012 10.1111/j.1399-0012.2004.00246.x 10.1097/00007890-200211150-00001 10.1111/ajt.13502 10.1371/journal.pone.0236396 10.1111/j.1399-3089.2006.00293.x 10.1172/JCI103085 10.1097/01.tp.0000231697.15817.51 10.1111/tri.12234 10.1016/j.transproceed.2016.06.048 10.1016/j.transproceed.2018.01.032 10.1016/j.trre.2012.07.003 10.1097/TP.0000000000001415 10.1111/j.1744-9987.2010.00821.x 10.1016/j.transproceed.2004.07.051 10.1056/NEJMoa1012376 10.3109/0886022X.2011.552149 10.1002/jca.21860 10.1016/j.krcp.2015.08.005 10.1016/j.transproceed.2008.06.110 10.3748/wjg.v26.i38.5797 10.4103/ijn.IJN_373_19 10.2215/CJN.11991019 |
| ContentType | Journal Article |
| Copyright | 2023 Elsevier B.V. Copyright © 2023 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2023 Elsevier B.V. – notice: Copyright © 2023 Elsevier B.V. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.trim.2023.101899 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1878-5492 |
| EndPage | 101899 |
| ExternalDocumentID | 10_1016_j_trim_2023_101899 37433394 S0966327423001168 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 36B 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM AAAJQ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXUO ABBQC ABDBF ABFRF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS CNWQP COF CS3 DU5 EAD EAP EAS EBS EBX EFJIC EFLBG EHN EJD EMB EMK EMOBN EO8 EO9 EP2 EP3 EPT ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMG HMK HMO HVGLF HZ~ IHE J1W KOM LCYCR LUGTX M29 M41 MO0 N9A O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SDF SDG SES SEW SIN SPCBC SSH SSI SSZ SV3 T5K UHS UNMZH WUQ Z5R ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c307t-22bea1471c1880c64b45607c6280cc4a6143bee978942438d543bc46fafcbc273 |
| IEDL.DBID | .~1 |
| ISSN | 0966-3274 |
| IngestDate | Fri Aug 16 08:03:15 EDT 2024 Thu Sep 26 16:33:31 EDT 2024 Sat Sep 28 08:19:47 EDT 2024 Fri Feb 23 02:35:39 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | ESRD SePE ABOi-KT FFP RRT USRDS IA CKD DFPP mPD Desensitization Antibody AMR MMF Rituximab IVIG KT CP NA ATG PD PE Basiliximab ABO incompatible kidney transplantation TAC HAR ABOc-KT HD |
| Language | English |
| License | Copyright © 2023 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c307t-22bea1471c1880c64b45607c6280cc4a6143bee978942438d543bc46fafcbc273 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| PMID | 37433394 |
| PQID | 2836293222 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | proquest_miscellaneous_2836293222 crossref_primary_10_1016_j_trim_2023_101899 pubmed_primary_37433394 elsevier_sciencedirect_doi_10_1016_j_trim_2023_101899 |
| PublicationCentury | 2000 |
| PublicationDate | October 2023 2023-Oct 2023-10-00 20231001 |
| PublicationDateYYYYMMDD | 2023-10-01 |
| PublicationDate_xml | – month: 10 year: 2023 text: October 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Transplant immunology |
| PublicationTitleAlternate | Transpl Immunol |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Morath, Zeier, Döhler, Opelz, Süsal (bb0460) 2017; 8 Tiwari, Aggarwal, Arora, Bhardwaj, Jain, Bansal (bb0260) 2020; 14 Holscher, Jackson, Segev (bb0040) 2020; 75 Kervella, Le Bas-Bernardet, Bruneau, Blancho (bb0120) 2022; 13 Lawrence, Galliford, Willicombe, McLean, Lesabe, Rowan (bb0205) 2011; 92 Itabashi, Sakai, Kawamura, Hyodo, Muramatsu, Arai (bb0525) 2004; 18 Koch, Wiech, Marget, Peine, Thude, Achilles (bb0515) 2015; 29 Hume, Merrill, Miller, Thorn (bb0045) 1955; 34 Hirose, Iwami, Hotta, Sasaki, Higuchi, Shinohara (bb0355) 2019; 51 Pandey, Setya, Sinha, Bhatt, Devra, Chaudhary (bb0210) 2021; 25 Razonable (bb0500) 2013; 27 Scurt, Ewert, Mertens, Haller, Schmidt, Chatzikyrkou (bb0130) 2019; 393 Pan, You, Wang, Fan, Ma, Chen (bb0310) 2023; 101 Sundling, Lau, Bourne, Young, Laurianto, Hermes (bb0095) 2021; 54 Hanaoka, Naganuma, Kabata, Morii, Takemoto, Uchida (bb0200) 2021; 50 Uchida, Machida, Iwai, Kuwabara, Kabei, Naganuma (bb0450) 2014; 28 Meesing, Razonable (bb0505) 2018; 78 Shah, Almeshari, Broering, Aleid, Brockmann, Alhumaidan (bb0535) 2019; 51 Jha, Tiwari, Bansal, Sethi, Ahlawat, Kher (bb0250) 2016; 56 Gloor, Lager, Fidler, Grande, Moore, Winters (bb0335) 2005; 80 Langhorst, Ganner, Schneider, Prager, Walz, Pisarski (bb0135) 2021; 53 Massie, Orandi, Waldram, Luo, Nguyen, Montgomery (bb0140) 2020; 76 Tanabe (bb0230) 2007; 84 Jordan, Legendre, Desai, Lorant, Bengtsson, Lonze (bb0295) 2021; 105 Kosoku, Iwai, Uchida (bb0520) 2022; 54 Chapman (bb0025) 2017; 69 Tiwari, Gupta, Divyaveer, Bhargava, Malik, Gupta (bb0265) 2021; 31 Tanabe, Tokumoto, Ishida, Toma, Nakajima, Fuchinoue (bb0420) 2003 Clark, Huang, Walsh, Farah, Hildebrand, Sontrop (bb0175) 2016; 90 Lo, Sharma, Craig, Wyburn, Lim, Chapman (bb0345) 2016; 100 Kahlyar, Roxby, Badrick, Vanniasinkam (bb0155) 2022; 117 Zhang, Guo, Ming (bb0125) 2020; 66 Gavriilidis, Inston (bb0030) 2020; 34 Koo, Yang (bb0190) 2015; 34 Zschiedrich, Jänigen, Dimova, Neumann, Seidl, Hils (bb0050) 2016; 31 Hatakeyama, Fujita, Murakami, Suzuki, Sugiyama, Yamamoto (bb0065) 2014; 46 Kim, Kang, Lee, Lee, Park (bb0180) 2021; 19 Barnett, Manook, Nagendran, Kenchayikoppad, Vaughan, Dorling (bb0225) 2014; 27 Nayak, Makroo, Prakash, Chandra, Agrawal, Chowdhry (bb0150) 2019; 23 de Weerd, Betjes (bb0470) 2018; 13 Ko, Yu, Yang, Chung, Korean Organ Transplantation Registry Study Group (bb0465) 2017; 30 Zachary, Leffell (bb0455) 2014; 258 Pandey, Setya, Sinha, Devra, Bhatt, Pande (bb0400) 2021; 36 Montgomery, Locke, King, Segev, Warren, Kraus (bb0370) 2009; 87 Nanmoku, Shinzato, Kubo, Shimizu, Kimura, Yagisawa (bb0440) 2018; 50 Haas, Mirocha, Reinsmoen, Vo, Choi, Kahwaji (bb0100) 2017; 91 Webster, Nagler, Morton, Masson (bb0005) 2017; 389 Thalgahagoda, Webb, Roberts, Birch, Milford, Tavakoli (bb0280) 2014; 18 Okada, Watarai, Iwasaki, Murotani, Futamura, Yamamoto (bb0365) 2017; 31 Bharadwaj, Shrestha, Pongracz, Concetta, Sharma, Le Moine (bb0300) 2022; 3 Cohen, Colvin, Daha, Drachenberg, Haas, Nickeleit (bb0110) 2012; 81 Mineshima (bb0240) 2017; 56 Chung, Lee, Kang, Sun, Choi, Park (bb0320) 2011; 33 Naciri Bennani, Noble, Chevallier, Terrec, Motte, Giroux-Lathuile (bb0245) 2021; 36 Chow, Flint, Shen, Landgren, Finlay, Murugasu (bb0215) 2017; 101 Ferrara, Zumla, Maeurer (bb0530) 2012; 125 Kato, Tojimbara, Iwadoh, Koyama, Nanmoku, Kai (bb0395) 2006; 6 Ray, Thukral (bb0165) 2017; 18 Ionescu, Urschel (bb0085) 2019; 103 Shinoda, Hyodo, Oguchi, Mikami, Nishikawa, Sakurabayashi (bb0375) 2022; 29 Kim, Choe, Shin, Kim, Han, Park (bb0425) 2020; 60 Staley, Carruba, Manning, Pham, Williams, Marques (bb0410) 2016; 16 Liyanage, Ninomiya, Jha, Neal, Patrice, Okpechi (bb0015) 2015; 385 Cooper (bb0185) 2020; 15 Tydén, Kumlien, Fehrman (bb0340) 2003; 76 Razonable, Humar (bb0495) 2019; 33 Shin, Kwon, Yang, Baeck, Yu, Cho (bb0430) 2015; 47 Ando, Tojimbara, Sato, Nakamura, Kawase, Kai (bb0390) 2004; 36 Hirzel, Projer, Atkinson, Surial, Mueller, Manuel (bb0475) 2022; 106 Nanmoku, Shinzato, Kubo, Shimizu, Kimura, Yagisawa (bb0445) 2018; 50 Okumi, Toki, Nozaki, Shimizu, Shirakawa, Omoto (bb0060) 2016; 16 Chikaraishi, Sasaki, Tsutsumi, Miyano, Nakazawa, Nakano (bb0360) 2008; 40 Muramatsu, Gonzalez, Cacciola, Aikawa, Yaqoob, Puliatti (bb0170) 2014; 4 Montgomery, Lonze, King, Kraus, Kucirka, Locke (bb0305) 2011; 365 Donauer, Wilpert, Geyer, Schwertfeger, Kirste, Drognitz (bb0285) 2006; 13 Ng, Ullah, Wilson, McDonald, Sypek, Mallett (bb0070) 2020; 15 Chung, Lim, Kim, Kim, Moon, Choi (bb0160) 2013; 124 Kuehn (bb0010) 2022; 327 Takahashi, Saito (bb0080) 2013; 27 Rivera, Rodriguez, Hermida, Jarrin, Muñiz, Saavedra (bb0315) 2021; 53 Ray, Thukral (bb0405) 2016; 48 Higgins, Lowe, Hathaway, Lam, Kashi, Tan (bb0255) 2010; 14 Hirano, Namazuda, Hirata (bb0235) 2021; 25 Orandi, Chow, Hsu, Gupta, Van Arendonk, Garonzik-Wang (bb0105) 2015; 15 Hanaoka, Naganuma, Kabata, Takemoto, Uchida, Nakatani (bb0195) 2020; 10 Tsai, Wu, Yang, Lee, Yeh, Hu (bb0325) 2015; 114 Sawada, Fuchinoue, Teraoka (bb0330) 2002; 74 de Weerd, van Agteren, Leebeek, Ijzermans, Weimar, Betjes (bb0290) 2015; 28 Sharp, Boyle, Diebolder, Kros, Koster, Gros (bb0090) 2019; 116 Schachtner, Stein, Reinke (bb0055) 2015; 28 Tanabe, Takahashi, Sonda, Tokumoto, Ishikawa, Kawai (bb0415) 1998; 65 Axelrod, Schnitzler, Xiao, Irish, Tuttle-Newhall, Chang (bb0145) 2018; 18 Voora, Adey (bb0020) 2019; 73 Masterson, Hughes, Walker, Hogan, Haeusler, Robertson (bb0220) 2014; 14 Thölking, Koch, Pavenstädt, Schuette-Nuetgen, Busch, Wolters (bb0275) 2015; 10 Becker, Siebert, Süsal, Opelz, Leo, Waldherr (bb0270) 2015; 99 Maenosono, Unagami, Kakuta, Furusawa, Okumi, Azuma (bb0350) 2019; 26 Thomusch, Wiesener, Opgenoorth, Pascher, Woitas, Witzke (bb0380) 2016; 388 de Weerd, van den Brand, Bouwsma, de Vries, Dooper, Sanders (bb0385) 2021; 34 Gioco, Corona, Ekser, Puzzo, Inserra, Pinto (bb0510) 2020; 26 Sørensen, Heaf, Wehberg, Sørensen (bb0035) 2016; 100 Yin, Tan, Yang, Zhang, Song, Fan (bb0485) 2022; 135 Hew, Kessaris, Stojanovic, Jones, Christian, Edwards (bb0435) 2023; 38 Lee, Kim, Lee, Song, Lee, Hwang (bb0480) 2021; 100 Breimer, Mölne, Nordén, Rydberg, Thiel, Svalander (bb0075) 2006; 82 Lee, Lee, Kim, Song, Kim, Kim (bb0490) 2016; 31 Kenta, Takaaki (bb0115) 2020; 144 Voora (10.1016/j.trim.2023.101899_bb0020) 2019; 73 Montgomery (10.1016/j.trim.2023.101899_bb0370) 2009; 87 Thomusch (10.1016/j.trim.2023.101899_bb0380) 2016; 388 Nanmoku (10.1016/j.trim.2023.101899_bb0445) 2018; 50 Thalgahagoda (10.1016/j.trim.2023.101899_bb0280) 2014; 18 Montgomery (10.1016/j.trim.2023.101899_bb0305) 2011; 365 Hanaoka (10.1016/j.trim.2023.101899_bb0200) 2021; 50 Lee (10.1016/j.trim.2023.101899_bb0480) 2021; 100 Kenta (10.1016/j.trim.2023.101899_bb0115) 2020; 144 Rivera (10.1016/j.trim.2023.101899_bb0315) 2021; 53 de Weerd (10.1016/j.trim.2023.101899_bb0385) 2021; 34 Gavriilidis (10.1016/j.trim.2023.101899_bb0030) 2020; 34 Tanabe (10.1016/j.trim.2023.101899_bb0415) 1998; 65 Sundling (10.1016/j.trim.2023.101899_bb0095) 2021; 54 Yin (10.1016/j.trim.2023.101899_bb0485) 2022; 135 Cohen (10.1016/j.trim.2023.101899_bb0110) 2012; 81 Thölking (10.1016/j.trim.2023.101899_bb0275) 2015; 10 Ferrara (10.1016/j.trim.2023.101899_bb0530) 2012; 125 Hume (10.1016/j.trim.2023.101899_bb0045) 1955; 34 Tydén (10.1016/j.trim.2023.101899_bb0340) 2003; 76 Morath (10.1016/j.trim.2023.101899_bb0460) 2017; 8 Clark (10.1016/j.trim.2023.101899_bb0175) 2016; 90 Razonable (10.1016/j.trim.2023.101899_bb0495) 2019; 33 Meesing (10.1016/j.trim.2023.101899_bb0505) 2018; 78 Kervella (10.1016/j.trim.2023.101899_bb0120) 2022; 13 Bharadwaj (10.1016/j.trim.2023.101899_bb0300) 2022; 3 Pan (10.1016/j.trim.2023.101899_bb0310) 2023; 101 Masterson (10.1016/j.trim.2023.101899_bb0220) 2014; 14 Chung (10.1016/j.trim.2023.101899_bb0320) 2011; 33 Ray (10.1016/j.trim.2023.101899_bb0405) 2016; 48 Mineshima (10.1016/j.trim.2023.101899_bb0240) 2017; 56 Chung (10.1016/j.trim.2023.101899_bb0160) 2013; 124 Tsai (10.1016/j.trim.2023.101899_bb0325) 2015; 114 Holscher (10.1016/j.trim.2023.101899_bb0040) 2020; 75 Zhang (10.1016/j.trim.2023.101899_bb0125) 2020; 66 Staley (10.1016/j.trim.2023.101899_bb0410) 2016; 16 Axelrod (10.1016/j.trim.2023.101899_bb0145) 2018; 18 Orandi (10.1016/j.trim.2023.101899_bb0105) 2015; 15 Breimer (10.1016/j.trim.2023.101899_bb0075) 2006; 82 Nayak (10.1016/j.trim.2023.101899_bb0150) 2019; 23 Kuehn (10.1016/j.trim.2023.101899_bb0010) 2022; 327 de Weerd (10.1016/j.trim.2023.101899_bb0470) 2018; 13 Schachtner (10.1016/j.trim.2023.101899_bb0055) 2015; 28 Sawada (10.1016/j.trim.2023.101899_bb0330) 2002; 74 Donauer (10.1016/j.trim.2023.101899_bb0285) 2006; 13 Barnett (10.1016/j.trim.2023.101899_bb0225) 2014; 27 Ando (10.1016/j.trim.2023.101899_bb0390) 2004; 36 Jha (10.1016/j.trim.2023.101899_bb0250) 2016; 56 Zachary (10.1016/j.trim.2023.101899_bb0455) 2014; 258 Gioco (10.1016/j.trim.2023.101899_bb0510) 2020; 26 Razonable (10.1016/j.trim.2023.101899_bb0500) 2013; 27 Hew (10.1016/j.trim.2023.101899_bb0435) 2023; 38 Kahlyar (10.1016/j.trim.2023.101899_bb0155) 2022; 117 Kosoku (10.1016/j.trim.2023.101899_bb0520) 2022; 54 Liyanage (10.1016/j.trim.2023.101899_bb0015) 2015; 385 Ng (10.1016/j.trim.2023.101899_bb0070) 2020; 15 Chapman (10.1016/j.trim.2023.101899_bb0025) 2017; 69 Kim (10.1016/j.trim.2023.101899_bb0180) 2021; 19 Chikaraishi (10.1016/j.trim.2023.101899_bb0360) 2008; 40 Shah (10.1016/j.trim.2023.101899_bb0535) 2019; 51 Shin (10.1016/j.trim.2023.101899_bb0430) 2015; 47 Itabashi (10.1016/j.trim.2023.101899_bb0525) 2004; 18 Okada (10.1016/j.trim.2023.101899_bb0365) 2017; 31 Hanaoka (10.1016/j.trim.2023.101899_bb0195) 2020; 10 Ko (10.1016/j.trim.2023.101899_bb0465) 2017; 30 Uchida (10.1016/j.trim.2023.101899_bb0450) 2014; 28 Lawrence (10.1016/j.trim.2023.101899_bb0205) 2011; 92 Zschiedrich (10.1016/j.trim.2023.101899_bb0050) 2016; 31 Gloor (10.1016/j.trim.2023.101899_bb0335) 2005; 80 Okumi (10.1016/j.trim.2023.101899_bb0060) 2016; 16 Ionescu (10.1016/j.trim.2023.101899_bb0085) 2019; 103 Ray (10.1016/j.trim.2023.101899_bb0165) 2017; 18 Sharp (10.1016/j.trim.2023.101899_bb0090) 2019; 116 Lo (10.1016/j.trim.2023.101899_bb0345) 2016; 100 Koch (10.1016/j.trim.2023.101899_bb0515) 2015; 29 Higgins (10.1016/j.trim.2023.101899_bb0255) 2010; 14 Hirose (10.1016/j.trim.2023.101899_bb0355) 2019; 51 Hatakeyama (10.1016/j.trim.2023.101899_bb0065) 2014; 46 Hirzel (10.1016/j.trim.2023.101899_bb0475) 2022; 106 Tanabe (10.1016/j.trim.2023.101899_bb0420) 2003 Tanabe (10.1016/j.trim.2023.101899_bb0230) 2007; 84 Naciri Bennani (10.1016/j.trim.2023.101899_bb0245) 2021; 36 Muramatsu (10.1016/j.trim.2023.101899_bb0170) 2014; 4 Nanmoku (10.1016/j.trim.2023.101899_bb0440) 2018; 50 Jordan (10.1016/j.trim.2023.101899_bb0295) 2021; 105 Webster (10.1016/j.trim.2023.101899_bb0005) 2017; 389 Sørensen (10.1016/j.trim.2023.101899_bb0035) 2016; 100 Massie (10.1016/j.trim.2023.101899_bb0140) 2020; 76 Haas (10.1016/j.trim.2023.101899_bb0100) 2017; 91 Becker (10.1016/j.trim.2023.101899_bb0270) 2015; 99 Maenosono (10.1016/j.trim.2023.101899_bb0350) 2019; 26 Kato (10.1016/j.trim.2023.101899_bb0395) 2006; 6 Chow (10.1016/j.trim.2023.101899_bb0215) 2017; 101 Kim (10.1016/j.trim.2023.101899_bb0425) 2020; 60 Langhorst (10.1016/j.trim.2023.101899_bb0135) 2021; 53 Hirano (10.1016/j.trim.2023.101899_bb0235) 2021; 25 Scurt (10.1016/j.trim.2023.101899_bb0130) 2019; 393 Lee (10.1016/j.trim.2023.101899_bb0490) 2016; 31 Takahashi (10.1016/j.trim.2023.101899_bb0080) 2013; 27 Pandey (10.1016/j.trim.2023.101899_bb0400) 2021; 36 Cooper (10.1016/j.trim.2023.101899_bb0185) 2020; 15 Tiwari (10.1016/j.trim.2023.101899_bb0265) 2021; 31 Pandey (10.1016/j.trim.2023.101899_bb0210) 2021; 25 Shinoda (10.1016/j.trim.2023.101899_bb0375) 2022; 29 Tiwari (10.1016/j.trim.2023.101899_bb0260) 2020; 14 Koo (10.1016/j.trim.2023.101899_bb0190) 2015; 34 de Weerd (10.1016/j.trim.2023.101899_bb0290) 2015; 28 |
| References_xml | – volume: 91 start-page: 729 year: 2017 end-page: 737 ident: bb0100 article-title: Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies publication-title: Kidney Int. contributor: fullname: Kahwaji – volume: 99 start-page: 2364 year: 2015 end-page: 2371 ident: bb0270 article-title: Outcomes following ABO-incompatible kidney transplantation performed after desensitization by nonantigen-specific Immunoadsorption publication-title: Transplantation contributor: fullname: Waldherr – volume: 51 start-page: 1382 year: 2019 end-page: 1386 ident: bb0355 article-title: Percentage of CD19+ cells in peripheral blood lymphocytes after rituximab-based desensitization as a predictor of acute antibody-mediated rejection in ABO-incompatible kidney transplantation publication-title: Transplant. Proc. contributor: fullname: Shinohara – volume: 14 start-page: 13 year: 2020 end-page: 18 ident: bb0260 article-title: Immunoadsorption in ABO-incompatible kidney transplantation in adult and pediatric patients with follow-up on graft and patient survival: first series from India publication-title: Asian J. Transfus. Sci. contributor: fullname: Bansal – volume: 54 start-page: 293 year: 2022 end-page: 298 ident: bb0520 article-title: Clinical outcomes of Everolimus with reduced-dose tacrolimus vs mycophenolate Mofetil with standard-dose tacrolimus in De novo ABO-incompatible kidney transplant recipients: 1-year follow-up publication-title: Transplant. Proc. contributor: fullname: Uchida – volume: 116 start-page: 11900 year: 2019 end-page: 11905 ident: bb0090 article-title: Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Gros – volume: 75 start-page: 114 year: 2020 end-page: 123 ident: bb0040 article-title: Transplanting the untransplantable publication-title: Am. J. Kidney Dis. contributor: fullname: Segev – volume: 103 start-page: 890 year: 2019 ident: bb0085 article-title: Memory B cells and long-lived plasma cells publication-title: Transplantation contributor: fullname: Urschel – volume: 81 start-page: 628 year: 2012 end-page: 639 ident: bb0110 article-title: Pros and cons for C4d as a biomarker publication-title: Kidney Int. contributor: fullname: Nickeleit – volume: 14 start-page: 392 year: 2010 end-page: 399 ident: bb0255 article-title: Double filtration plasmapheresis in antibody-incompatible kidney transplantation publication-title: Ther. Apher. Dial. contributor: fullname: Tan – volume: 60 start-page: 598 year: 2020 end-page: 606 ident: bb0425 article-title: ABO-incompatible kidney transplantation can be successfully conducted by monitoring IgM isoagglutinin titers during desensitization publication-title: Transfusion contributor: fullname: Park – volume: 69 start-page: 287 year: 2017 end-page: 295 ident: bb0025 article-title: Progress in transplantation: will it be achieved in big steps or by marginal gains? publication-title: Am. J. Kidney Dis. contributor: fullname: Chapman – volume: 33 year: 2019 ident: bb0495 article-title: Cytomegalovirus in solid organ transplant recipients-guidelines of the American Society of Transplantation Infectious Diseases Community of Practice publication-title: Clin. Transpl. contributor: fullname: Humar – volume: 34 year: 2020 ident: bb0030 article-title: Recipient and allograft survival following donation after circulatory death versus donation after brain death for renal transplantation: a systematic review and meta-analysis publication-title: Transplant. Rev. (Orlando) contributor: fullname: Inston – volume: 106 start-page: 1875 year: 2022 end-page: 1883 ident: bb0475 article-title: Infection risk in the first year after ABO-incompatible kidney transplantation: a nationwide prospective cohort study publication-title: Transplantation contributor: fullname: Manuel – volume: 4 start-page: 18 year: 2014 end-page: 29 ident: bb0170 article-title: ABO incompatible renal transplants: good or bad? publication-title: World J. Transplant. contributor: fullname: Puliatti – volume: 80 start-page: 1572 year: 2005 end-page: 1577 ident: bb0335 article-title: A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation publication-title: Transplantation contributor: fullname: Winters – volume: 258 start-page: 183 year: 2014 end-page: 207 ident: bb0455 article-title: Desensitization for solid organ and hematopoietic stem cell transplantation publication-title: Immunol. Rev. contributor: fullname: Leffell – volume: 29 start-page: 1021 year: 2015 end-page: 1028 ident: bb0515 article-title: De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation publication-title: Clin. Transpl. contributor: fullname: Achilles – volume: 28 start-page: 1179 year: 2015 end-page: 1194 ident: bb0055 article-title: ABO desensitization affects cellular immunity and infection control after renal transplantation publication-title: Transpl. Int. contributor: fullname: Reinke – volume: 34 start-page: 170 year: 2015 end-page: 179 ident: bb0190 article-title: Current progress in ABO-incompatible kidney transplantation publication-title: Kidney Res. Clin. Pract. contributor: fullname: Yang – volume: 327 start-page: 1540 year: 2022 ident: bb0010 article-title: End-stage kidney disease doubles publication-title: JAMA contributor: fullname: Kuehn – volume: 73 start-page: 866 year: 2019 end-page: 879 ident: bb0020 article-title: Management of kidney transplant recipients by general nephrologists: core curriculum 2019 publication-title: Am. J. Kidney Dis. contributor: fullname: Adey – volume: 33 start-page: 150 year: 2011 end-page: 158 ident: bb0320 article-title: Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation publication-title: Ren. Fail. contributor: fullname: Park – volume: 28 start-page: 25 year: 2015 end-page: 33 ident: bb0290 article-title: ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption publication-title: Transpl. Int. contributor: fullname: Betjes – volume: 47 start-page: 1720 year: 2015 end-page: 1726 ident: bb0430 article-title: Long-term outcomes of ABO-incompatible living donor kidney transplantation: a comparative analysis publication-title: Transplant. Proc. contributor: fullname: Cho – volume: 40 start-page: 3445 year: 2008 end-page: 3447 ident: bb0360 article-title: ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab publication-title: Transplant. Proc. contributor: fullname: Nakano – volume: 27 start-page: 187 year: 2014 end-page: 196 ident: bb0225 article-title: Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation publication-title: Transpl. Int. contributor: fullname: Dorling – volume: 26 start-page: 1114 year: 2019 end-page: 1120 ident: bb0350 article-title: Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation publication-title: Int. J. Urol. contributor: fullname: Azuma – volume: 16 start-page: 2483 year: 2016 end-page: 2486 ident: bb0410 article-title: Anti-blood group antibodies in intravenous immunoglobulin may complicate interpretation of antibody titers in ABO-incompatible transplantation publication-title: Am. J. Transplant. contributor: fullname: Marques – volume: 90 start-page: 974 year: 2016 end-page: 984 ident: bb0175 article-title: Plasmapheresis for the treatment of kidney diseases publication-title: Kidney Int. contributor: fullname: Sontrop – volume: 13 year: 2022 ident: bb0120 article-title: Protection of transplants against antibody-mediated injuries: from xenotransplantation to allogeneic transplantation, mechanisms and therapeutic insights publication-title: Front. Immunol. contributor: fullname: Blancho – volume: 14 start-page: 2807 year: 2014 end-page: 2813 ident: bb0220 article-title: ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone publication-title: Am. J. Transplant. contributor: fullname: Robertson – volume: 8 start-page: 234 year: 2017 ident: bb0460 article-title: ABO-incompatible kidney transplantation publication-title: Front. Immunol. contributor: fullname: Süsal – volume: 34 start-page: 327 year: 1955 end-page: 382 ident: bb0045 article-title: Experiences with renal homotransplantation in the human: report of nine cases publication-title: J. Clin. Invest. contributor: fullname: Thorn – volume: 31 start-page: 33 year: 2021 end-page: 38 ident: bb0265 article-title: Immunoadsorption column reuse publication-title: Indian J. Nephrol. contributor: fullname: Gupta – volume: 78 start-page: 1085 year: 2018 end-page: 1103 ident: bb0505 article-title: New developments in the management of cytomegalovirus infection after transplantation publication-title: Drugs contributor: fullname: Razonable – volume: 27 start-page: 1 year: 2013 end-page: 8 ident: bb0080 article-title: ABO-incompatible kidney transplantation publication-title: Transplant. Rev. (Orlando) contributor: fullname: Saito – volume: 13 start-page: 1234 year: 2018 end-page: 1243 ident: bb0470 article-title: ABO-incompatible kidney transplant outcomes: a meta-analysis publication-title: Clin. J. Am. Soc. Nephrol. contributor: fullname: Betjes – volume: 117 start-page: 109 year: 2022 end-page: 118 ident: bb0155 article-title: Challenges in antibody titration for ABO-incompatible renal transplantation publication-title: Vox Sang. contributor: fullname: Vanniasinkam – volume: 101 start-page: 115 year: 2023 end-page: 123 ident: bb0310 article-title: The impact of preformed and de novo HLA-DP antibodies in renal transplantation, a meta-analysis publication-title: HLA contributor: fullname: Chen – volume: 16 start-page: 886 year: 2016 end-page: 896 ident: bb0060 article-title: ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management publication-title: Am. J. Transplant. contributor: fullname: Omoto – volume: 38 start-page: 529 year: 2023 end-page: 535 ident: bb0435 article-title: Successful ABO and HLA incompatible kidney transplantation in children in the UK publication-title: Pediatr. Nephrol. contributor: fullname: Edwards – volume: 56 start-page: 956 year: 2016 end-page: 961 ident: bb0250 article-title: Cascade plasmapheresis as preconditioning regimen for ABO-incompatible renal transplantation: a single-center experience publication-title: Transfusion contributor: fullname: Kher – volume: 388 start-page: 3006 year: 2016 end-page: 3016 ident: bb0380 article-title: Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial publication-title: Lancet contributor: fullname: Witzke – volume: 25 start-page: 145 year: 2021 end-page: 151 ident: bb0235 article-title: Double filtration plasmapheresis: review of current clinical applications publication-title: Ther. Apher. Dial. contributor: fullname: Hirata – volume: 15 year: 2020 ident: bb0070 article-title: ABO blood group relationships to kidney transplant recipient and graft outcomes publication-title: PLoS One contributor: fullname: Mallett – volume: 46 start-page: 445 year: 2014 end-page: 448 ident: bb0065 article-title: Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience publication-title: Transplant. Proc. contributor: fullname: Yamamoto – volume: 100 start-page: 2160 year: 2016 end-page: 2167 ident: bb0035 article-title: Survival benefit in renal transplantation despite high comorbidity publication-title: Transplantation contributor: fullname: Sørensen – volume: 76 start-page: 730 year: 2003 end-page: 731 ident: bb0340 article-title: Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab publication-title: Transplantation contributor: fullname: Fehrman – volume: 66 start-page: 1229 year: 2020 end-page: 1234 ident: bb0125 article-title: Effects of hemodialysis, peritoneal dialysis, and renal transplantation on the quality of life of patients with end-stage renal disease publication-title: Rev. Assoc. Med. Bras. contributor: fullname: Ming – volume: 36 start-page: 149 year: 2021 end-page: 160 ident: bb0245 article-title: Isoagglutinin removal by plasma centrifugation or filtration (single or double): a prospective study in a single center publication-title: J. Clin. Apher. contributor: fullname: Giroux-Lathuile – volume: 114 start-page: 353 year: 2015 end-page: 358 ident: bb0325 article-title: B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis publication-title: J. Formos. Med. Assoc. contributor: fullname: Hu – volume: 10 start-page: 1434 year: 2020 ident: bb0195 article-title: Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma publication-title: Sci. Rep. contributor: fullname: Nakatani – volume: 124 start-page: 79 year: 2013 end-page: 88 ident: bb0160 article-title: Impact of the baseline anti-A/B antibody titer on the clinical outcome in ABO-incompatible kidney transplantation publication-title: Nephron Clin. Pract. contributor: fullname: Choi – volume: 82 start-page: 479 year: 2006 end-page: 485 ident: bb0075 article-title: Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status publication-title: Transplantation contributor: fullname: Svalander – volume: 50 start-page: 829 year: 2021 end-page: 836 ident: bb0200 article-title: Safety and efficacy of tandem hemodialysis and selective plasma exchange in pretransplant desensitization of ABO-incompatible kidney transplantation publication-title: Blood Purif. contributor: fullname: Uchida – volume: 18 start-page: E74 year: 2014 end-page: E76 ident: bb0280 article-title: Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption publication-title: Pediatr. Transplant. contributor: fullname: Tavakoli – volume: 36 start-page: 2182 year: 2004 end-page: 2183 ident: bb0390 article-title: Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: a rapid steroid withdrawal protocol publication-title: Transplant. Proc. contributor: fullname: Kai – volume: 25 start-page: 103 year: 2021 end-page: 117 ident: bb0210 article-title: Therapeutic apheresis in ABO-incompatible kidney and liver transplantation: a single-center experience of 50 patients publication-title: Ther. Apher. Dial. contributor: fullname: Chaudhary – volume: 74 start-page: 1207 year: 2002 end-page: 1210 ident: bb0330 article-title: Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis publication-title: Transplantation contributor: fullname: Teraoka – start-page: 175 year: 2003 end-page: 181 ident: bb0420 article-title: ABO-incompatible renal transplantation at Tokyo Women’s medical university publication-title: Clin. Transpl. contributor: fullname: Fuchinoue – volume: 50 start-page: 1050 year: 2018 end-page: 1055 ident: bb0445 article-title: Steroid withdrawal using Everolimus in ABO-incompatible kidney transplant recipients with post-transplant diabetes mellitus publication-title: Transplant. Proc. contributor: fullname: Yagisawa – volume: 34 start-page: 2706 year: 2021 end-page: 2719 ident: bb0385 article-title: ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis publication-title: Transpl. Int. contributor: fullname: Sanders – volume: 19 start-page: 102 year: 2021 end-page: 112 ident: bb0180 article-title: Perioperative blood usage and therapeutic plasma exchange in kidney transplantation during a 16-year period in South Korea publication-title: Blood Transfus. contributor: fullname: Park – volume: 18 start-page: 39 year: 2004 end-page: 43 ident: bb0525 article-title: BK virus nephropathy in a patient with ABO-incompatible renal transplantation publication-title: Clin. Transpl. contributor: fullname: Arai – volume: 29 start-page: 1017 year: 2022 end-page: 1025 ident: bb0375 article-title: Outcome of ABO-incompatible kidney transplantation using a modified desensitization protocol without plasmapheresis publication-title: Int. J. Urol. contributor: fullname: Sakurabayashi – volume: 389 start-page: 1238 year: 2017 end-page: 1252 ident: bb0005 article-title: Chronic kidney disease publication-title: Lancet contributor: fullname: Masson – volume: 393 start-page: 2059 year: 2019 end-page: 2072 ident: bb0130 article-title: Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis publication-title: Lancet contributor: fullname: Chatzikyrkou – volume: 48 start-page: 2622 year: 2016 end-page: 2628 ident: bb0405 article-title: Outcome of ABO-incompatible living donor renal transplantations: a single-center experience from eastern India publication-title: Transplant. Proc. contributor: fullname: Thukral – volume: 23 start-page: 86 year: 2019 end-page: 91 ident: bb0150 article-title: Comparative evaluation of five different methods of anti-ABO antibody titration: an aid for ABO-incompatible organ transplants publication-title: Ther. Apher. Dial. contributor: fullname: Chowdhry – volume: 87 start-page: 1246 year: 2009 end-page: 1255 ident: bb0370 article-title: ABO incompatible renal transplantation: a paradigm ready for broad implementation publication-title: Transplantation contributor: fullname: Kraus – volume: 65 start-page: 224 year: 1998 end-page: 228 ident: bb0415 article-title: Long-term results of ABO-incompatible living kidney transplantation: a single-center experience publication-title: Transplantation contributor: fullname: Kawai – volume: 31 year: 2017 ident: bb0365 article-title: Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: advantages and disadvantages of rituximab pretreatment publication-title: Clin. Transpl. contributor: fullname: Yamamoto – volume: 31 start-page: 663 year: 2016 end-page: 671 ident: bb0050 article-title: One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience publication-title: Nephrol. Dial. Transplant. contributor: fullname: Hils – volume: 125 year: 2012 ident: bb0530 article-title: Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections publication-title: Am. J. Med. contributor: fullname: Maeurer – volume: 15 start-page: 489 year: 2015 end-page: 498 ident: bb0105 article-title: Quantifying renal allograft loss following early antibody-mediated rejection publication-title: Am. J. Transplant. contributor: fullname: Garonzik-Wang – volume: 53 start-page: 848 year: 2021 end-page: 855 ident: bb0135 article-title: Long-term follow-up of ABO-incompatible kidney transplantation in Freiburg, Germany: a single-center outcome report publication-title: Transplant. Proc. contributor: fullname: Pisarski – volume: 30 start-page: 1215 year: 2017 end-page: 1225 ident: bb0465 article-title: Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study publication-title: Transpl. Int. contributor: fullname: Korean Organ Transplantation Registry Study Group – volume: 53 start-page: 2675 year: 2021 end-page: 2677 ident: bb0315 article-title: Isoagglutinin titers in ABO-incompatible kidney transplant publication-title: Transplant. Proc. contributor: fullname: Saavedra – volume: 84 start-page: S30 year: 2007 end-page: S32 ident: bb0230 article-title: Double-filtration plasmapheresis publication-title: Transplantation contributor: fullname: Tanabe – volume: 54 start-page: 988 year: 2021 end-page: 1001.e5 ident: bb0095 article-title: Positive selection of IgG+ over IgM+ B cells in the germinal center reaction publication-title: Immunity contributor: fullname: Hermes – volume: 105 start-page: 1808 year: 2021 end-page: 1817 ident: bb0295 article-title: Imlifidase desensitization in crossmatch-positive, highly sensitized kidney transplant recipients: results of an international phase 2 trial (Highdes) publication-title: Transplantation contributor: fullname: Lonze – volume: 365 start-page: 318 year: 2011 end-page: 326 ident: bb0305 article-title: Desensitization in HLA-incompatible kidney recipients and survival publication-title: N. Engl. J. Med. contributor: fullname: Locke – volume: 18 start-page: 1073 year: 2017 end-page: 1076 ident: bb0165 article-title: ABO-incompatible renal transplantation with high antibody titer: a case report publication-title: Am. J. Case Rep. contributor: fullname: Thukral – volume: 3 year: 2022 ident: bb0300 article-title: Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation publication-title: Cell Rep. Med. contributor: fullname: Le Moine – volume: 385 start-page: 1975 year: 2015 end-page: 1982 ident: bb0015 article-title: Worldwide access to treatment for end-stage kidney disease: a systematic review publication-title: Lancet contributor: fullname: Okpechi – volume: 76 start-page: 616 year: 2020 end-page: 623 ident: bb0140 article-title: Impact of ABO-incompatible living donor kidney transplantation on patient survival publication-title: Am. J. Kidney Dis. contributor: fullname: Montgomery – volume: 28 start-page: 80 year: 2014 end-page: 87 ident: bb0450 article-title: Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs–a short-term pilot study publication-title: Clin. Transpl. contributor: fullname: Naganuma – volume: 31 start-page: 1013 year: 2016 end-page: 1021 ident: bb0490 article-title: The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation publication-title: Nephrol. Dial. Transplant. contributor: fullname: Kim – volume: 26 start-page: 5797 year: 2020 end-page: 5811 ident: bb0510 article-title: Gastrointestinal complications after kidney transplantation publication-title: World J. Gastroenterol. contributor: fullname: Pinto – volume: 10 year: 2015 ident: bb0275 article-title: Antigen-specific versus non-antigen-specific immunoadsorption in ABO-incompatible renal transplantation publication-title: PLoS One contributor: fullname: Wolters – volume: 144 start-page: 2 year: 2020 end-page: 6 ident: bb0115 article-title: Molecular mechanisms of antibody-mediated rejection and accommodation in organ transplantation publication-title: Nephron contributor: fullname: Takaaki – volume: 56 start-page: 654 year: 2017 end-page: 656 ident: bb0240 article-title: Double filtration plasmapheresis: determination of the optimal albumin concentration in the supplementation fluid publication-title: Transfus. Apher. Sci. contributor: fullname: Mineshima – volume: 6 start-page: 1984 year: 2006 end-page: 1992 ident: bb0395 article-title: Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients publication-title: Int. Immunopharmacol. contributor: fullname: Kai – volume: 135 start-page: 2303 year: 2022 end-page: 2310 ident: bb0485 article-title: Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation publication-title: Chin. Med. J. contributor: fullname: Fan – volume: 101 start-page: 1433 year: 2017 end-page: 1440 ident: bb0215 article-title: Histological and extended clinical outcomes after ABO-incompatible renal transplantation without splenectomy or rituximab publication-title: Transplantation contributor: fullname: Murugasu – volume: 100 start-page: 933 year: 2016 end-page: 942 ident: bb0345 article-title: Preconditioning therapy in ABO-incompatible living kidney transplantation: a systematic review and Meta-analysis publication-title: Transplantation contributor: fullname: Chapman – volume: 50 start-page: 982 year: 2018 end-page: 986 ident: bb0440 article-title: Desensitization with the use of an antibody removal-free protocol in ABO-incompatible kidney transplant recipients with a low anti-a/B antibody titer publication-title: Transplant. Proc. contributor: fullname: Yagisawa – volume: 27 start-page: 317 year: 2013 end-page: 342 ident: bb0500 article-title: Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients publication-title: Infect. Dis. Clin. N. Am. contributor: fullname: Razonable – volume: 100 year: 2021 ident: bb0480 article-title: Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation: a network meta-analysis publication-title: Medicine (Baltimore) contributor: fullname: Hwang – volume: 51 start-page: 512 year: 2019 end-page: 516 ident: bb0535 article-title: ABO-incompatible kidney transplantation: low rates of infectious complications and excellent patient survival publication-title: Transplant. Proc. contributor: fullname: Alhumaidan – volume: 13 start-page: 108 year: 2006 end-page: 110 ident: bb0285 article-title: ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience publication-title: Xenotransplantation contributor: fullname: Drognitz – volume: 15 start-page: 430 year: 2020 end-page: 438 ident: bb0185 article-title: Evaluation and treatment of acute rejection in kidney allografts publication-title: Clin. J. Am. Soc. Nephrol. contributor: fullname: Cooper – volume: 18 start-page: 1168 year: 2018 end-page: 1176 ident: bb0145 article-title: An economic assessment of contemporary kidney transplant practice publication-title: Am. J. Transplant. contributor: fullname: Chang – volume: 36 start-page: 299 year: 2021 end-page: 312 ident: bb0400 article-title: Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: single center experience of first 200 incompatible transplants publication-title: J. Clin. Apher. contributor: fullname: Pande – volume: 92 start-page: 1129 year: 2011 end-page: 1133 ident: bb0205 article-title: Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic? publication-title: Transplantation contributor: fullname: Rowan – volume: 103 start-page: 890 issue: 5 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0085 article-title: Memory B cells and long-lived plasma cells publication-title: Transplantation doi: 10.1097/TP.0000000000002594 contributor: fullname: Ionescu – volume: 60 start-page: 598 issue: 3 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0425 article-title: ABO-incompatible kidney transplantation can be successfully conducted by monitoring IgM isoagglutinin titers during desensitization publication-title: Transfusion doi: 10.1111/trf.15672 contributor: fullname: Kim – volume: 105 start-page: 1808 issue: 8 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0295 article-title: Imlifidase desensitization in crossmatch-positive, highly sensitized kidney transplant recipients: results of an international phase 2 trial (Highdes) publication-title: Transplantation doi: 10.1097/TP.0000000000003496 contributor: fullname: Jordan – volume: 47 start-page: 1720 issue: 6 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0430 article-title: Long-term outcomes of ABO-incompatible living donor kidney transplantation: a comparative analysis publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2015.05.026 contributor: fullname: Shin – volume: 87 start-page: 1246 issue: 8 year: 2009 ident: 10.1016/j.trim.2023.101899_bb0370 article-title: ABO incompatible renal transplantation: a paradigm ready for broad implementation publication-title: Transplantation doi: 10.1097/TP.0b013e31819f2024 contributor: fullname: Montgomery – volume: 6 start-page: 1984 issue: 13–14 year: 2006 ident: 10.1016/j.trim.2023.101899_bb0395 article-title: Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2006.07.018 contributor: fullname: Kato – volume: 53 start-page: 2675 issue: 9 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0315 article-title: Isoagglutinin titers in ABO-incompatible kidney transplant publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2021.07.059 contributor: fullname: Rivera – volume: 18 start-page: E74 issue: 3 year: 2014 ident: 10.1016/j.trim.2023.101899_bb0280 article-title: Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption publication-title: Pediatr. Transplant. doi: 10.1111/petr.12227 contributor: fullname: Thalgahagoda – volume: 30 start-page: 1215 issue: 12 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0465 article-title: Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study publication-title: Transpl. Int. doi: 10.1111/tri.12979 contributor: fullname: Ko – volume: 54 start-page: 988 issue: 5 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0095 article-title: Positive selection of IgG+ over IgM+ B cells in the germinal center reaction publication-title: Immunity doi: 10.1016/j.immuni.2021.03.013 contributor: fullname: Sundling – volume: 14 start-page: 13 issue: 1 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0260 article-title: Immunoadsorption in ABO-incompatible kidney transplantation in adult and pediatric patients with follow-up on graft and patient survival: first series from India publication-title: Asian J. Transfus. Sci. doi: 10.4103/ajts.AJTS_82_19 contributor: fullname: Tiwari – volume: 19 start-page: 102 issue: 2 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0180 article-title: Perioperative blood usage and therapeutic plasma exchange in kidney transplantation during a 16-year period in South Korea publication-title: Blood Transfus. contributor: fullname: Kim – volume: 117 start-page: 109 issue: 1 year: 2022 ident: 10.1016/j.trim.2023.101899_bb0155 article-title: Challenges in antibody titration for ABO-incompatible renal transplantation publication-title: Vox Sang. doi: 10.1111/vox.13160 contributor: fullname: Kahlyar – volume: 124 start-page: 79 issue: 1–2 year: 2013 ident: 10.1016/j.trim.2023.101899_bb0160 article-title: Impact of the baseline anti-A/B antibody titer on the clinical outcome in ABO-incompatible kidney transplantation publication-title: Nephron Clin. Pract. doi: 10.1159/000355855 contributor: fullname: Chung – volume: 76 start-page: 616 issue: 5 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0140 article-title: Impact of ABO-incompatible living donor kidney transplantation on patient survival publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2020.03.029 contributor: fullname: Massie – volume: 31 start-page: 663 issue: 4 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0050 article-title: One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfv388 contributor: fullname: Zschiedrich – volume: 385 start-page: 1975 issue: 9981 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0015 article-title: Worldwide access to treatment for end-stage kidney disease: a systematic review publication-title: Lancet doi: 10.1016/S0140-6736(14)61601-9 contributor: fullname: Liyanage – volume: 14 start-page: 2807 issue: 12 year: 2014 ident: 10.1016/j.trim.2023.101899_bb0220 article-title: ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone publication-title: Am. J. Transplant. doi: 10.1111/ajt.12920 contributor: fullname: Masterson – volume: 80 start-page: 1572 issue: 11 year: 2005 ident: 10.1016/j.trim.2023.101899_bb0335 article-title: A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation publication-title: Transplantation doi: 10.1097/01.tp.0000184622.69708.c1 contributor: fullname: Gloor – volume: 101 start-page: 115 issue: 2 year: 2023 ident: 10.1016/j.trim.2023.101899_bb0310 article-title: The impact of preformed and de novo HLA-DP antibodies in renal transplantation, a meta-analysis publication-title: HLA doi: 10.1111/tan.14879 contributor: fullname: Pan – volume: 28 start-page: 80 issue: 1 year: 2014 ident: 10.1016/j.trim.2023.101899_bb0450 article-title: Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs–a short-term pilot study publication-title: Clin. Transpl. doi: 10.1111/ctr.12281 contributor: fullname: Uchida – volume: 31 start-page: 1013 issue: 6 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0490 article-title: The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfw017 contributor: fullname: Lee – volume: 23 start-page: 86 issue: 1 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0150 article-title: Comparative evaluation of five different methods of anti-ABO antibody titration: an aid for ABO-incompatible organ transplants publication-title: Ther. Apher. Dial. doi: 10.1111/1744-9987.12745 contributor: fullname: Nayak – volume: 46 start-page: 445 issue: 2 year: 2014 ident: 10.1016/j.trim.2023.101899_bb0065 article-title: Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2013.09.036 contributor: fullname: Hatakeyama – volume: 4 start-page: 18 issue: 1 year: 2014 ident: 10.1016/j.trim.2023.101899_bb0170 article-title: ABO incompatible renal transplants: good or bad? publication-title: World J. Transplant. doi: 10.5500/wjt.v4.i1.18 contributor: fullname: Muramatsu – volume: 73 start-page: 866 issue: 6 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0020 article-title: Management of kidney transplant recipients by general nephrologists: core curriculum 2019 publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2019.01.031 contributor: fullname: Voora – volume: 25 start-page: 145 issue: 2 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0235 article-title: Double filtration plasmapheresis: review of current clinical applications publication-title: Ther. Apher. Dial. doi: 10.1111/1744-9987.13548 contributor: fullname: Hirano – volume: 29 start-page: 1017 issue: 9 year: 2022 ident: 10.1016/j.trim.2023.101899_bb0375 article-title: Outcome of ABO-incompatible kidney transplantation using a modified desensitization protocol without plasmapheresis publication-title: Int. J. Urol. doi: 10.1111/iju.14944 contributor: fullname: Shinoda – volume: 388 start-page: 3006 issue: 10063 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0380 article-title: Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(16)32187-0 contributor: fullname: Thomusch – volume: 34 start-page: 2706 issue: 12 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0385 article-title: ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis publication-title: Transpl. Int. doi: 10.1111/tri.14145 contributor: fullname: de Weerd – volume: 144 start-page: 2 issue: Suppl. 1 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0115 article-title: Molecular mechanisms of antibody-mediated rejection and accommodation in organ transplantation publication-title: Nephron doi: 10.1159/000510747 contributor: fullname: Kenta – volume: 50 start-page: 829 issue: 6 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0200 article-title: Safety and efficacy of tandem hemodialysis and selective plasma exchange in pretransplant desensitization of ABO-incompatible kidney transplantation publication-title: Blood Purif. doi: 10.1159/000512713 contributor: fullname: Hanaoka – volume: 91 start-page: 729 issue: 3 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0100 article-title: Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies publication-title: Kidney Int. doi: 10.1016/j.kint.2016.10.040 contributor: fullname: Haas – volume: 116 start-page: 11900 issue: 24 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0090 article-title: Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1901841116 contributor: fullname: Sharp – volume: 84 start-page: S30 issue: 12 Suppl year: 2007 ident: 10.1016/j.trim.2023.101899_bb0230 article-title: Double-filtration plasmapheresis publication-title: Transplantation doi: 10.1097/01.tp.0000296103.34735.b8 contributor: fullname: Tanabe – volume: 76 start-page: 730 issue: 4 year: 2003 ident: 10.1016/j.trim.2023.101899_bb0340 article-title: Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab publication-title: Transplantation doi: 10.1097/01.TP.0000078622.43689.D4 contributor: fullname: Tydén – volume: 34 issue: 4 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0030 article-title: Recipient and allograft survival following donation after circulatory death versus donation after brain death for renal transplantation: a systematic review and meta-analysis publication-title: Transplant. Rev. (Orlando) doi: 10.1016/j.trre.2020.100563 contributor: fullname: Gavriilidis – volume: 18 start-page: 1168 issue: 5 year: 2018 ident: 10.1016/j.trim.2023.101899_bb0145 article-title: An economic assessment of contemporary kidney transplant practice publication-title: Am. J. Transplant. doi: 10.1111/ajt.14702 contributor: fullname: Axelrod – volume: 92 start-page: 1129 issue: 10 year: 2011 ident: 10.1016/j.trim.2023.101899_bb0205 article-title: Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic? publication-title: Transplantation doi: 10.1097/TP.0b013e31823360cf contributor: fullname: Lawrence – volume: 56 start-page: 654 issue: 5 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0240 article-title: Double filtration plasmapheresis: determination of the optimal albumin concentration in the supplementation fluid publication-title: Transfus. Apher. Sci. doi: 10.1016/j.transci.2017.08.009 contributor: fullname: Mineshima – volume: 393 start-page: 2059 issue: 10185 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0130 article-title: Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis publication-title: Lancet doi: 10.1016/S0140-6736(18)32091-9 contributor: fullname: Scurt – volume: 15 start-page: 489 issue: 2 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0105 article-title: Quantifying renal allograft loss following early antibody-mediated rejection publication-title: Am. J. Transplant. doi: 10.1111/ajt.12982 contributor: fullname: Orandi – volume: 51 start-page: 1382 issue: 5 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0355 article-title: Percentage of CD19+ cells in peripheral blood lymphocytes after rituximab-based desensitization as a predictor of acute antibody-mediated rejection in ABO-incompatible kidney transplantation publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2019.01.127 contributor: fullname: Hirose – volume: 31 issue: 10 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0365 article-title: Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: advantages and disadvantages of rituximab pretreatment publication-title: Clin. Transpl. doi: 10.1111/ctr.13071 contributor: fullname: Okada – volume: 106 start-page: 1875 issue: 9 year: 2022 ident: 10.1016/j.trim.2023.101899_bb0475 article-title: Infection risk in the first year after ABO-incompatible kidney transplantation: a nationwide prospective cohort study publication-title: Transplantation doi: 10.1097/TP.0000000000004109 contributor: fullname: Hirzel – volume: 66 start-page: 1229 issue: 9 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0125 article-title: Effects of hemodialysis, peritoneal dialysis, and renal transplantation on the quality of life of patients with end-stage renal disease publication-title: Rev. Assoc. Med. Bras. doi: 10.1590/1806-9282.66.9.1229 contributor: fullname: Zhang – volume: 51 start-page: 512 issue: 2 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0535 article-title: ABO-incompatible kidney transplantation: low rates of infectious complications and excellent patient survival publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2019.01.002 contributor: fullname: Shah – volume: 100 start-page: 2160 issue: 10 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0035 article-title: Survival benefit in renal transplantation despite high comorbidity publication-title: Transplantation doi: 10.1097/TP.0000000000001002 contributor: fullname: Sørensen – volume: 75 start-page: 114 issue: 1 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0040 article-title: Transplanting the untransplantable publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2019.04.025 contributor: fullname: Holscher – volume: 36 start-page: 149 issue: 1 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0245 article-title: Isoagglutinin removal by plasma centrifugation or filtration (single or double): a prospective study in a single center publication-title: J. Clin. Apher. doi: 10.1002/jca.21857 contributor: fullname: Naciri Bennani – volume: 13 year: 2022 ident: 10.1016/j.trim.2023.101899_bb0120 article-title: Protection of transplants against antibody-mediated injuries: from xenotransplantation to allogeneic transplantation, mechanisms and therapeutic insights publication-title: Front. Immunol. doi: 10.3389/fimmu.2022.932242 contributor: fullname: Kervella – volume: 16 start-page: 2483 issue: 8 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0410 article-title: Anti-blood group antibodies in intravenous immunoglobulin may complicate interpretation of antibody titers in ABO-incompatible transplantation publication-title: Am. J. Transplant. doi: 10.1111/ajt.13760 contributor: fullname: Staley – volume: 33 issue: 9 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0495 article-title: Cytomegalovirus in solid organ transplant recipients-guidelines of the American Society of Transplantation Infectious Diseases Community of Practice publication-title: Clin. Transpl. doi: 10.1111/ctr.13512 contributor: fullname: Razonable – volume: 25 start-page: 103 issue: 1 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0210 article-title: Therapeutic apheresis in ABO-incompatible kidney and liver transplantation: a single-center experience of 50 patients publication-title: Ther. Apher. Dial. doi: 10.1111/1744-9987.13495 contributor: fullname: Pandey – volume: 69 start-page: 287 issue: 2 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0025 article-title: Progress in transplantation: will it be achieved in big steps or by marginal gains? publication-title: Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2016.08.024 contributor: fullname: Chapman – volume: 18 start-page: 1073 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0165 article-title: ABO-incompatible renal transplantation with high antibody titer: a case report publication-title: Am. J. Case Rep. doi: 10.12659/AJCR.905633 contributor: fullname: Ray – volume: 56 start-page: 956 issue: 4 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0250 article-title: Cascade plasmapheresis as preconditioning regimen for ABO-incompatible renal transplantation: a single-center experience publication-title: Transfusion doi: 10.1111/trf.13427 contributor: fullname: Jha – volume: 90 start-page: 974 issue: 5 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0175 article-title: Plasmapheresis for the treatment of kidney diseases publication-title: Kidney Int. doi: 10.1016/j.kint.2016.06.009 contributor: fullname: Clark – volume: 125 issue: 10 year: 2012 ident: 10.1016/j.trim.2023.101899_bb0530 article-title: Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections publication-title: Am. J. Med. doi: 10.1016/j.amjmed.2012.01.023 contributor: fullname: Ferrara – volume: 99 start-page: 2364 issue: 11 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0270 article-title: Outcomes following ABO-incompatible kidney transplantation performed after desensitization by nonantigen-specific Immunoadsorption publication-title: Transplantation doi: 10.1097/TP.0000000000000753 contributor: fullname: Becker – volume: 78 start-page: 1085 issue: 11 year: 2018 ident: 10.1016/j.trim.2023.101899_bb0505 article-title: New developments in the management of cytomegalovirus infection after transplantation publication-title: Drugs doi: 10.1007/s40265-018-0943-1 contributor: fullname: Meesing – volume: 258 start-page: 183 issue: 1 year: 2014 ident: 10.1016/j.trim.2023.101899_bb0455 article-title: Desensitization for solid organ and hematopoietic stem cell transplantation publication-title: Immunol. Rev. doi: 10.1111/imr.12150 contributor: fullname: Zachary – volume: 27 start-page: 317 issue: 2 year: 2013 ident: 10.1016/j.trim.2023.101899_bb0500 article-title: Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients publication-title: Infect. Dis. Clin. N. Am. doi: 10.1016/j.idc.2013.02.005 contributor: fullname: Razonable – volume: 65 start-page: 224 issue: 2 year: 1998 ident: 10.1016/j.trim.2023.101899_bb0415 article-title: Long-term results of ABO-incompatible living kidney transplantation: a single-center experience publication-title: Transplantation doi: 10.1097/00007890-199801270-00014 contributor: fullname: Tanabe – volume: 38 start-page: 529 issue: 2 year: 2023 ident: 10.1016/j.trim.2023.101899_bb0435 article-title: Successful ABO and HLA incompatible kidney transplantation in children in the UK publication-title: Pediatr. Nephrol. doi: 10.1007/s00467-022-05583-5 contributor: fullname: Hew – volume: 50 start-page: 1050 issue: 4 year: 2018 ident: 10.1016/j.trim.2023.101899_bb0445 article-title: Steroid withdrawal using Everolimus in ABO-incompatible kidney transplant recipients with post-transplant diabetes mellitus publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2018.01.028 contributor: fullname: Nanmoku – volume: 389 start-page: 1238 issue: 10075 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0005 article-title: Chronic kidney disease publication-title: Lancet doi: 10.1016/S0140-6736(16)32064-5 contributor: fullname: Webster – volume: 13 start-page: 1234 issue: 8 year: 2018 ident: 10.1016/j.trim.2023.101899_bb0470 article-title: ABO-incompatible kidney transplant outcomes: a meta-analysis publication-title: Clin. J. Am. Soc. Nephrol. doi: 10.2215/CJN.00540118 contributor: fullname: de Weerd – volume: 135 start-page: 2303 issue: 19 year: 2022 ident: 10.1016/j.trim.2023.101899_bb0485 article-title: Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation publication-title: Chin. Med. J. doi: 10.1097/CM9.0000000000002138 contributor: fullname: Yin – volume: 327 start-page: 1540 issue: 16 year: 2022 ident: 10.1016/j.trim.2023.101899_bb0010 article-title: End-stage kidney disease doubles publication-title: JAMA contributor: fullname: Kuehn – volume: 3 issue: 11 year: 2022 ident: 10.1016/j.trim.2023.101899_bb0300 article-title: Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation publication-title: Cell Rep. Med. contributor: fullname: Bharadwaj – volume: 100 issue: 10 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0480 article-title: Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation: a network meta-analysis publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000024853 contributor: fullname: Lee – volume: 54 start-page: 293 issue: 2 year: 2022 ident: 10.1016/j.trim.2023.101899_bb0520 article-title: Clinical outcomes of Everolimus with reduced-dose tacrolimus vs mycophenolate Mofetil with standard-dose tacrolimus in De novo ABO-incompatible kidney transplant recipients: 1-year follow-up publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2021.08.062 contributor: fullname: Kosoku – volume: 10 start-page: 1434 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0195 article-title: Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma publication-title: Sci. Rep. doi: 10.1038/s41598-020-58436-2 contributor: fullname: Hanaoka – volume: 10 issue: 6 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0275 article-title: Antigen-specific versus non-antigen-specific immunoadsorption in ABO-incompatible renal transplantation publication-title: PLoS One doi: 10.1371/journal.pone.0131465 contributor: fullname: Thölking – volume: 100 start-page: 933 issue: 4 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0345 article-title: Preconditioning therapy in ABO-incompatible living kidney transplantation: a systematic review and Meta-analysis publication-title: Transplantation doi: 10.1097/TP.0000000000000933 contributor: fullname: Lo – volume: 26 start-page: 1114 issue: 12 year: 2019 ident: 10.1016/j.trim.2023.101899_bb0350 article-title: Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation publication-title: Int. J. Urol. doi: 10.1111/iju.14108 contributor: fullname: Maenosono – volume: 28 start-page: 1179 issue: 10 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0055 article-title: ABO desensitization affects cellular immunity and infection control after renal transplantation publication-title: Transpl. Int. doi: 10.1111/tri.12616 contributor: fullname: Schachtner – volume: 53 start-page: 848 issue: 3 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0135 article-title: Long-term follow-up of ABO-incompatible kidney transplantation in Freiburg, Germany: a single-center outcome report publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2020.09.001 contributor: fullname: Langhorst – volume: 28 start-page: 25 issue: 1 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0290 article-title: ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption publication-title: Transpl. Int. doi: 10.1111/tri.12412 contributor: fullname: de Weerd – volume: 29 start-page: 1021 issue: 11 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0515 article-title: De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation publication-title: Clin. Transpl. doi: 10.1111/ctr.12624 contributor: fullname: Koch – volume: 8 start-page: 234 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0460 article-title: ABO-incompatible kidney transplantation publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.00234 contributor: fullname: Morath – volume: 81 start-page: 628 issue: 7 year: 2012 ident: 10.1016/j.trim.2023.101899_bb0110 article-title: Pros and cons for C4d as a biomarker publication-title: Kidney Int. doi: 10.1038/ki.2011.497 contributor: fullname: Cohen – volume: 114 start-page: 353 issue: 4 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0325 article-title: B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis publication-title: J. Formos. Med. Assoc. doi: 10.1016/j.jfma.2012.12.012 contributor: fullname: Tsai – start-page: 175 year: 2003 ident: 10.1016/j.trim.2023.101899_bb0420 article-title: ABO-incompatible renal transplantation at Tokyo Women’s medical university publication-title: Clin. Transpl. contributor: fullname: Tanabe – volume: 18 start-page: 39 issue: s11 year: 2004 ident: 10.1016/j.trim.2023.101899_bb0525 article-title: BK virus nephropathy in a patient with ABO-incompatible renal transplantation publication-title: Clin. Transpl. doi: 10.1111/j.1399-0012.2004.00246.x contributor: fullname: Itabashi – volume: 74 start-page: 1207 issue: 9 year: 2002 ident: 10.1016/j.trim.2023.101899_bb0330 article-title: Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis publication-title: Transplantation doi: 10.1097/00007890-200211150-00001 contributor: fullname: Sawada – volume: 16 start-page: 886 issue: 3 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0060 article-title: ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management publication-title: Am. J. Transplant. doi: 10.1111/ajt.13502 contributor: fullname: Okumi – volume: 15 issue: 7 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0070 article-title: ABO blood group relationships to kidney transplant recipient and graft outcomes publication-title: PLoS One doi: 10.1371/journal.pone.0236396 contributor: fullname: Ng – volume: 13 start-page: 108 issue: 2 year: 2006 ident: 10.1016/j.trim.2023.101899_bb0285 article-title: ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience publication-title: Xenotransplantation doi: 10.1111/j.1399-3089.2006.00293.x contributor: fullname: Donauer – volume: 34 start-page: 327 issue: 2 year: 1955 ident: 10.1016/j.trim.2023.101899_bb0045 article-title: Experiences with renal homotransplantation in the human: report of nine cases publication-title: J. Clin. Invest. doi: 10.1172/JCI103085 contributor: fullname: Hume – volume: 82 start-page: 479 issue: 4 year: 2006 ident: 10.1016/j.trim.2023.101899_bb0075 article-title: Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status publication-title: Transplantation doi: 10.1097/01.tp.0000231697.15817.51 contributor: fullname: Breimer – volume: 27 start-page: 187 issue: 2 year: 2014 ident: 10.1016/j.trim.2023.101899_bb0225 article-title: Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation publication-title: Transpl. Int. doi: 10.1111/tri.12234 contributor: fullname: Barnett – volume: 48 start-page: 2622 issue: 8 year: 2016 ident: 10.1016/j.trim.2023.101899_bb0405 article-title: Outcome of ABO-incompatible living donor renal transplantations: a single-center experience from eastern India publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2016.06.048 contributor: fullname: Ray – volume: 50 start-page: 982 issue: 4 year: 2018 ident: 10.1016/j.trim.2023.101899_bb0440 article-title: Desensitization with the use of an antibody removal-free protocol in ABO-incompatible kidney transplant recipients with a low anti-a/B antibody titer publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2018.01.032 contributor: fullname: Nanmoku – volume: 27 start-page: 1 issue: 1 year: 2013 ident: 10.1016/j.trim.2023.101899_bb0080 article-title: ABO-incompatible kidney transplantation publication-title: Transplant. Rev. (Orlando) doi: 10.1016/j.trre.2012.07.003 contributor: fullname: Takahashi – volume: 101 start-page: 1433 issue: 6 year: 2017 ident: 10.1016/j.trim.2023.101899_bb0215 article-title: Histological and extended clinical outcomes after ABO-incompatible renal transplantation without splenectomy or rituximab publication-title: Transplantation doi: 10.1097/TP.0000000000001415 contributor: fullname: Chow – volume: 14 start-page: 392 issue: 4 year: 2010 ident: 10.1016/j.trim.2023.101899_bb0255 article-title: Double filtration plasmapheresis in antibody-incompatible kidney transplantation publication-title: Ther. Apher. Dial. doi: 10.1111/j.1744-9987.2010.00821.x contributor: fullname: Higgins – volume: 36 start-page: 2182 issue: 7 year: 2004 ident: 10.1016/j.trim.2023.101899_bb0390 article-title: Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: a rapid steroid withdrawal protocol publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2004.07.051 contributor: fullname: Ando – volume: 365 start-page: 318 issue: 4 year: 2011 ident: 10.1016/j.trim.2023.101899_bb0305 article-title: Desensitization in HLA-incompatible kidney recipients and survival publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1012376 contributor: fullname: Montgomery – volume: 33 start-page: 150 issue: 2 year: 2011 ident: 10.1016/j.trim.2023.101899_bb0320 article-title: Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation publication-title: Ren. Fail. doi: 10.3109/0886022X.2011.552149 contributor: fullname: Chung – volume: 36 start-page: 299 issue: 3 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0400 article-title: Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: single center experience of first 200 incompatible transplants publication-title: J. Clin. Apher. doi: 10.1002/jca.21860 contributor: fullname: Pandey – volume: 34 start-page: 170 issue: 3 year: 2015 ident: 10.1016/j.trim.2023.101899_bb0190 article-title: Current progress in ABO-incompatible kidney transplantation publication-title: Kidney Res. Clin. Pract. doi: 10.1016/j.krcp.2015.08.005 contributor: fullname: Koo – volume: 40 start-page: 3445 issue: 10 year: 2008 ident: 10.1016/j.trim.2023.101899_bb0360 article-title: ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab publication-title: Transplant. Proc. doi: 10.1016/j.transproceed.2008.06.110 contributor: fullname: Chikaraishi – volume: 26 start-page: 5797 issue: 38 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0510 article-title: Gastrointestinal complications after kidney transplantation publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v26.i38.5797 contributor: fullname: Gioco – volume: 31 start-page: 33 issue: 1 year: 2021 ident: 10.1016/j.trim.2023.101899_bb0265 article-title: Immunoadsorption column reuse publication-title: Indian J. Nephrol. doi: 10.4103/ijn.IJN_373_19 contributor: fullname: Tiwari – volume: 15 start-page: 430 issue: 3 year: 2020 ident: 10.1016/j.trim.2023.101899_bb0185 article-title: Evaluation and treatment of acute rejection in kidney allografts publication-title: Clin. J. Am. Soc. Nephrol. doi: 10.2215/CJN.11991019 contributor: fullname: Cooper |
| SSID | ssj0002597 |
| Score | 2.4053485 |
| SecondaryResourceType | review_article |
| Snippet | ABO incompatibility has long been considered an absolute contraindication for kidney transplantation. However, with the increasing number of patients with ESRD... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 101899 |
| SubjectTerms | ABO Blood-Group System ABO incompatible kidney transplantation Antibodies Antibody Basiliximab Blood Group Incompatibility Desensitization Graft Rejection - prevention & control Graft Survival Humans Immunosuppression Therapy - methods Kidney Transplantation Living Donors Rituximab |
| Title | Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients |
| URI | https://dx.doi.org/10.1016/j.trim.2023.101899 https://www.ncbi.nlm.nih.gov/pubmed/37433394 https://search.proquest.com/docview/2836293222 |
| Volume | 80 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5EUbyIb9cXEbxJ3bVJu-1xXZT1LT7AW0jSFOqjW9Z62Iu_3ZmmVQT14KmkpDRMkpmvnfm-AOyqkHeUDg48o5OOJ1JtcEv5XS-OVRClESmKE8H54jIc3IvTh-BhAvoNF4bKKmvf73x65a3rO-3amu0iy9q3CL5DXmUaq2wCEX4FBiNc0_vvX2UeCO8ryjR29qh3TZxxNV7lKCM2us_pRlTpv_4YnH4Dn1UQOp6HuRo9sp4b4AJM2HwRpt15kuNFmLmoM-VL8NhzyX36-ceynBUjOyysk_lmCVGOqFjLcTCZI2GNGQJY1ju8YqTY8EKl1vrZsqcsye2YlZUK-rNyVKWckSpGQWTK12W4Pz666w-8-lwFz-COLj3f11YdYFQyJMZmQqERRXW6JvSxZYTCiM21tfh9GQtf8CgJsG1EmKrUaIN4ZwUm82Fu14DFQpFUOanqcdH1VRTgxOtOGqlQi0gkLdhrDCoLJ58hm7qyR0nml2R-6czfgqCxufy2CCT69z-f22kmSOLuoJSHyu3w7VUieAoR0CAIasGqm7nPcXAET5zHYv2fb92AWWq5yr5NmCxHb3YLEUqpt6sluA1Tvf7N-TVdT84Glx-eIubn |
| link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwEB2VVnxc0FJYKOyCV-KGoraxkybHsmLVbj84bCv1ZtmOI2W3m0Zt9tB_z0ycVEICDhzjxIo1tmdeMvOeAb6qkA-UDoae0cnAE6k2uKX8kRfHKojSiBTFieC8WIaTtbjdBJsWXDdcGCqrrH2_8-mVt65b-rU1-0WW9e8QfIe8yjRW2YToGXREMBqKNnTG09lkeXLIiPAr1jQ-71GHmjvjyrzKfUaEdJ9TQ1RJwP4xPv0Nf1Zx6OYMXtcAko3dGN9Ay-ZdeO6OlDx24cWiTpa_hfuxy-_T_z-W5azY211hndI3S4h1RPVajobJHA_ryBDDsvH3n4xEGx6p2lpvLXvIktweWVkJoW-VYyvljIQxCuJTHt7B-ubH6nri1UcreAY3den5vrZqiIHJkB6bCYVGIDUYmdDHKyMUBm2urcVPzFj4gkdJgNdGhKlKjTYIec6hne9y-wFYLBSplZOwHhcjX0UBzr0epJEKtYhE0oNvjUFl4RQ0ZFNadi_J_JLML535exA0Npe_rQOJLv6f_a6aCZK4QSjroXK7ezpIxE8hYhrEQT1472buNA6O-InzWHz8z7d-gZeT1WIu59Pl7BO8ojuu0O8C2uX-yV4iYCn153pB_gJeL-gI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advancement+in+preoperative+desensitization+therapy+for+ABO+incompatible+kidney+transplantation+recipients&rft.jtitle=Transplant+immunology&rft.au=Ma%2C+Yuhua&rft.au=Man%2C+Jiangwei&rft.au=Gui%2C+Huiming&rft.au=Niu%2C+Jiping&rft.date=2023-10-01&rft.pub=Elsevier+B.V&rft.issn=0966-3274&rft.eissn=1878-5492&rft.volume=80&rft_id=info:doi/10.1016%2Fj.trim.2023.101899&rft.externalDocID=S0966327423001168 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0966-3274&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0966-3274&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0966-3274&client=summon |